Clinical Trials
71 trialsOCTANE
University Health Network, Toronto
COPD Care Pathway Among Patients With Cancer
Wake Forest University Health Sciences
Collecting Blood Samples From Patients With and Without Cancer to Evaluate Tests for Early Cancer Detection
Alliance for Clinical Trials in Oncology
OvAR-Y
Washington University School of Medicine
SHERLOCK
University Health Network, Toronto
iCaRe2
University of Nebraska
ELEPHAS-02
Elephas
Sub-topic Four: Clinical Translation of Original Radioactive Drugs for Precision Diagnosis and Treatment of Gastrointestinal Tumors -Clinical Application Value of PET Imaging Targeting LRRC15 in Malignant Tumors
Union Hospital, Tongji Medical College, Huazhong University of Science and Technology
Evaluation of Improved Onboard Patient Imaging
Varian, a Siemens Healthineers Company
TraveraRTGx
Travera Inc
GALENOS 1
Fondazione del Piemonte per l'Oncologia
ALTAK
Centre Oscar Lambret
MOMENTUM
UMC Utrecht
QVA-Mod
Hospices Civils de Lyon
Circulating Tumor DNA (ctDNA) for Early Treatment Response Assessment of Solid Tumors
Washington University School of Medicine
Immunobiology Blood and Tissue Collection of Upper Aerodigestive Malignancies
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
Laryngopharyngeal Injury After Endotracheal Intubation Under General Anesthesia
Zhejiang University
CAMPERR
Adela, Inc
SCORE
Natera, Inc.
LIBERATE
University Health Network, Toronto
SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry
Massive Bio, Inc.
SMALLHAN
Hospices Civils de Lyon
Biomarkers in Patients With Respiratory Tract Dysplasia or Lung Cancer, Head and Neck Cancer, or Aerodigestive Tract Cancer and in Normal Volunteers
University of Colorado, Denver
DART
Aalborg University Hospital
DELFI-L101
Delfi Diagnostics Inc.
Identification of Secreted Markers for Tumor Hypoxia in Patients With Head and Neck or Lung Cancers
Stanford University
Tempus Priority Study: A Pan-tumor Observational Study
Tempus AI
18F Labeled FAP Targeted Molecular Probe in Early Tumor Diagnosis
Nanjing First Hospital, Nanjing Medical University
Genomic Testing and Resulting Medical Decisions
Arbeitsgemeinschaft medikamentoese Tumortherapie
99mTc Labeled FAP Targeted Molecular Probe in Early Diagnosis of Tumors
Nanjing First Hospital, Nanjing Medical University
PREFER
Labcorp Corporation of America Holdings, Inc
MOM
Inova Health Care Services
FUTURE
Assistance Publique Hopitaux De Marseille
MOHCCN-O
University Health Network, Toronto
Improving Evidence-Based Care for Cancer Patients
Medical University of South Carolina
ROOT
Taproot Health
Defining the Clinical Potential of Mass Response As a Biomarker for Patient Tumor Sensitivity to Drugs
Travera Inc
QUANTUM
VitaMed Research LLC
SkinHealth
Fondazione Policlinico Universitario Agostino Gemelli IRCCS
A Multicentre Study on Features of the Gut Microbiota of Patients With Critical Chronic Diseases in China
Zhujiang Hospital
Plasma Metabolic Biomarkers for Multi-Cancer Diagnosis
Beijing Friendship Hospital
Radiogenomics in Aerodigestive Tract Cancers
Buddhist Tzu Chi General Hospital
POSITive
European Institute of Oncology
MORRIS
Umeå University
Developing Artificial Intelligence-based Algorism to Predict Side Effects and Symptoms From Chemotherapy
Samsung Medical Center
G-DEFINER
Fondazione IRCCS Istituto Nazionale dei Tumori, Milano
Clinical Study of Pan-cancer DNA Methylation Test in Plasma
Wuhan Ammunition Life-tech Co., Ltd
Oral Glutamine and Thoracic/Upper Aerodigestive Tumors Radiation Toxicity
National and Kapodistrian University of Athens
External Control, Observational, Retrospective Study Comparing Pralsetinib to Best Available Therapy in Patients With RET-Fusion Positive NSCLC
Blueprint Medicines Corporation
PIONEER
SpeciCare